A clinical case of Crohn’s disease in combination with spondyloarthritis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a clinical observation of a patient with combined clinical course of Crohn’s disease and ankylosing spondylitis – chronic inflammatory diseases from the group of immune-inflammatory pathologies. Despite their different clinical focuses – gastrointestinal in case of Crohn’s disease and musculoskeletal in spondylitis – these diseases share common pathogenetic mechanisms. However, their coexistence in the same patient is rare and is of particular interest both from a diagnostic and therapeutic perspective. Such cases require a multidisciplinary approach to the patient and individualized therapy selection.

Full Text

Restricted Access

About the authors

Vladimir V. Pavlenko

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: pavlenkovv@yandex.ru
ORCID iD: 0009-0007-7717-0840

MD, Dr. Sci. (Medicine), professor, head of the Department of internal medicine propaedeutics

Russian Federation, Stavropol

Gulnara A. Eseneeva

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: gulj081181@yandex.ru
ORCID iD: 0009-0001-0415-7334

MD, PhD (Medicine), associate professor of the Department of internal medicine propaedeutics

Russian Federation, Stavropol

Saida O. Muradbekova

Stavropol State Medical University of the Ministry of Healthcare of Russia

Author for correspondence.
Email: muradbekowa@yandex.ru
ORCID iD: 0009-0002-9059-6401

MD, assistant at the Department of internal medicine propaedeutics

Russian Federation, Stavropol

Svetlana B. Aleksandrova

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: AleksandrovaSB@yandex.ru
ORCID iD: 0009-0001-0219-2240

MD, PhD (Medicine), associate professor of the Department of internal medicine propaedeutics

Russian Federation, Stavropol

Vladimir V. Alferov

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: v.v.alferov@mail.ru
ORCID iD: 0009-0008-0207-4480

MD, PhD (Medicine), assistant professor of the Department of internal medicine propaedeutics

Russian Federation, Stavropol

References

  1. Клинические рекомендации. Болезнь Крона. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендация Минздрава России. 2024. ID: 176_2. Доступ: https://cr.minzdrav.gov.ru/view-cr/176_2 (дата обращения – 27.10.2025). [Clinical guidelines. Crohn’s disease. Association of Proctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2024. ID: 176_2. URL: https://cr.minzdrav.gov.ru/view-cr/176_2 (date of access – 27.10.2025) (In Russ.)].
  2. Белоусова Е.А., Шелыгин Ю.А., Ачкасов С.И., Хатьков И.Е., Бакулин И.Г., Скалинская М.И. с соавт. Клинико-демографические характеристики и лечебные подходы у пациентов с воспалительными заболеваниями кишечника (болезнь Крона, язвенный колит) в РФ. Первые результаты анализа Национального регистра. Колопроктология. 2023;22(1):65–82. [Belousova EA, Shelygin YuA, Achkasov SI, Khatkov IE, Bakulin IG, Skalinskaya MI et al. Clinical and demographic features and treatment approaches for inflammatory bowel diseases (Crohn’s disease, ulcerative colitis) in Russia. The primary results of the analysis of the National Register. Koloproktologiya = Coloproctology. 2023;22(1):65–82 (In Russ.)]. EDN: IMBCQN. https://doi.org/10.33878/2073-7556-2023-22-1-65-822023
  3. Gomollon F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO et al. European evidence-based consensus on the diagnosis and management of Crohn`s disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25. PMID: 27660341. https://doi.org/10.1093/ecco-jcc/jjw168
  4. Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: Current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161(4):1118–32. PMID: 34358489. PMCID: PMC8564770. https://doi.org/10.1053/j.gastro.2021.07.042
  5. Luchetti MM, Benfaremo D, Bendia E, Bolognini L, Fava G, Marini F et al. Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis. Eur J Intern Med. 2019;64:76–84. PMID: 31047747. https://doi.org/10.1016/j.ejim.2019.04.015
  6. Bieber A, Fawaz A, Novofastovski I, Mader R. Antitumor necrosis factor-alpha therapy associated with inflammatory bowel disease: Three cases and a systematic literature review. J Rheumatol. 2017;44(7):1088–95. PMID: 28412712. https://doi.org/10.3899/jrheum.160952
  7. Guillo L, D’Amico F, Danese S, Peyrin-Biroulet L. Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: A systematic literature review. J Crohns Colitis. 2021;15(7):1236–43. PMID: 33367674. https://doi.org/10.1093/ecco-jcc/jjaa260

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 “Bionika Media” LLC